ORGANOGENESIS HOLDINGS INC.

ORGO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016
Revenue $198.5M $138.7M
Cost of Revenue $61.2M $48.2M
Gross Profit $137.3M $90.5M
Gross Margin 69.2% 65.3%
Operating Expenses
Research & Development $9.1M $6.3M
SG&A Expense $133.7M $93.0M
Operating Income $-5.5M $-8.8M
Operating Margin -2.8% -6.3%
Interest Expense $8.0M $5.6M
Pretax Income $-14.6M $-14.7M
Income Tax Expense $-7.0M $65.0K
Net Income $-8.4M $-17.0M
Net Margin -4.2% -12.2%
EPS (Basic) $-0.14 $-0.27
EPS (Diluted) $-0.14 $-0.27
Shares Outstanding (Basic) 67.0M
Shares Outstanding (Diluted) 67.0M
Dividends Per Share
← Newer Page 2 of 2 Older →